XLON
EMVC
Market cap16mUSD
Oct 21, Last price
52.50GBP
Name
Netscientific PLC
Chart & Performance
P/E
—
P/S
5.13
EPS
—
Div Yield, %
—
Shrs. gr., 5y
25.31%
Rev. gr., 5y
27.23%
Revenues
2m
+69.55%
Net income
-3m
L+15.70%
CFO
-2m
L-43.20%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NetScientific plc operates as a venture capital entity, strategically deploying capital into companies at their initial, emergent, and growth stages. Its primary investment interests lie in sustainability, advanced technology, and groundbreaking biomedical and healthcare innovations. Within the healthcare sphere, the firm specifically targets digital health, diagnostics, and therapeutics, with a particular emphasis on ventures that enhance the well-being and health outcomes for individuals suffering from chronic diseases. Its digital health focus encompasses data analytics, wearable technologies, and various medical devices. Geographically, NetScientific actively seeks opportunities in established European markets and across the United States. While typical investments may reach £15 million (approximately $20.32 million), the firm is prepared to commit larger sums. A core strategy is to secure a controlling interest in its principal subsidiary companies, with funding predominantly sourced from its own balance sheet. NetScientific plc was established in 2008 and is headquartered in London, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||